THC Therapeutics Company Insiders
| THCT Stock | USD 0.0003 0.00 0.00% |
THC Therapeutics employs about 1 people. The company is managed by 2 executives with a total tenure of roughly 3 years, averaging almost 1.0 years of service per executive, having 0.5 employees per reported executive. Breaking down THC Therapeutics' management performance can provide insight into the firm performance.
| Victor Nacif Insider Head Design |
| Brandon Romanek Insider CFO, CEO |
THC |
THC Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of (5.5725) % which means that it has lost $5.5725 on every $100 spent on assets. This is way below average. THC Therapeutics' management efficiency ratios could be used to measure how well THC Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.THC Therapeutics Workforce Comparison
THC Therapeutics is rated second in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 75,541. THC Therapeutics adds roughly 1.0 in number of employees claiming only tiny portion of equities under Health Care industry.
THC Therapeutics Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. THC Therapeutics Price Series Summation is a cross summation of THC Therapeutics price series and its benchmark/peer.
THC Therapeutics Notable Stakeholders
A THC Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as THC Therapeutics often face trade-offs trying to please all of them. THC Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting THC Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Victor Nacif | Head Design | Profile | |
| Brandon Romanek | CFO, CEO | Profile |
About THC Therapeutics Management Performance
The success or failure of an entity such as THC Therapeutics often depends on how effective the management is. THC Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of THC management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the THC management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
It is involved in the development of dHydronator, a sanitizing herb dryer for drying and sanitizing of freshly harvested cannabis, other herbs, flowers, and tea leaves. THC Therapeutics, Inc. was incorporated in 2007 and is based in Las Vegas, Nevada. Thc Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1 people.
Please note, the imprecision that can be found in THC Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of THC Therapeutics. Check THC Therapeutics' Beneish M Score to see the likelihood of THC Therapeutics' management manipulating its earnings.
THC Therapeutics Workforce Analysis
Traditionally, organizations such as THC Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare THC Therapeutics within its industry.THC Therapeutics Manpower Efficiency
Return on THC Therapeutics Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1.9M | |
| Net Loss Per Executive | 942.7K |
Additional Tools for THC Pink Sheet Analysis
When running THC Therapeutics' price analysis, check to measure THC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy THC Therapeutics is operating at the current time. Most of THC Therapeutics' value examination focuses on studying past and present price action to predict the probability of THC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move THC Therapeutics' price. Additionally, you may evaluate how the addition of THC Therapeutics to your portfolios can decrease your overall portfolio volatility.